We are live on ! Find out more
Belvedere Trading

Belvedere Trading Portfolio holdings

AUM $87.6B
1-Year Est. Return 131.08%
This Fund
S&P 500
This Quarter Est. Return
+25.91%
1 Year Est. Return
+131.08%
3 Year Est. Return
+497.29%
5 Year Est. Return
+787.25%
10 Year Est. Return
AUM
$41.3B
AUM Growth
+$4.26B
Cap. Flow
-$462M
Cap. Flow %
-1.12%
Top 10 Hldgs %
91.6%
Holding
1,678
New
553
Increased
134
Reduced
156
Closed
796

Sector Composition

Rank Sector Weight
1 Communication Services 0.07%
2 Consumer Discretionary 0.06%
3 Technology 0.02%
4 Healthcare 0.02%
5 Industrials 0.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABCL icon
876
AbCellera Biologics
ABCL
$1.86B
-1,861
Closed -$16.9K
ACHR icon
877
CALL
Archer Aviation
ACHR
$4.05B
-4,500
Closed -$8.41K
ACHR icon
878
Archer Aviation
ACHR
$4.05B
-9,421
Closed -$17.6K
ACHR icon
879
PUT
Archer Aviation
ACHR
$4.05B
-10,100
Closed -$18.9K
ACI icon
880
CALL
Albertsons Companies
ACI
$5.86B
-26,600
Closed -$552K
ACI icon
881
Albertsons Companies
ACI
$5.86B
-1,606
Closed -$33.3K
ACI icon
882
PUT
Albertsons Companies
ACI
$5.86B
-1,200
Closed -$24.9K
ADMA icon
883
CALL
ADMA Biologics
ADMA
$2.07B
-7,900
Closed -$30.7K
ADMA icon
884
PUT
ADMA Biologics
ADMA
$2.07B
-20,800
Closed -$80.7K
ADPT icon
885
CALL
Adaptive Biotechnologies
ADPT
$3.9B
-10,000
Closed -$76.4K
ADPT icon
886
Adaptive Biotechnologies
ADPT
$3.9B
-986
Closed -$7.53K
ADVM
887
CALL
DELISTED
Adverum Biotechnologies
ADVM
-950
Closed -$5.51K
ADVM
888
PUT
DELISTED
Adverum Biotechnologies
ADVM
-100
Closed -$580
AEHR icon
889
CALL
Aehr Test Systems
AEHR
$3.58B
-3,900
Closed -$78.4K
AEHR icon
890
Aehr Test Systems
AEHR
$3.58B
-14,070
Closed -$283K
AEVA
891
Aeva Technologies
AEVA
$1.4B
-2,263
Closed -$15.4K
AGYS icon
892
Agilysys
AGYS
$3.14B
-1,679
Closed -$136K
AGYS icon
893
PUT
Agilysys
AGYS
$3.14B
-1,800
Closed -$142K
AIRS icon
894
AirSculpt Technologies
AIRS
$350M
-18,526
Closed -$68.5K
AKBA icon
895
CALL
Akebia Therapeutics
AKBA
$354M
-14,300
Closed -$8.25K
AKBA icon
896
Akebia Therapeutics
AKBA
$354M
-100
Closed -$58
AKBA icon
897
PUT
Akebia Therapeutics
AKBA
$354M
-100
Closed -$58
ALLT icon
898
Allot
ALLT
$401M
-9,927
Closed -$34.1K
ALLT icon
899
PUT
Allot
ALLT
$401M
-12,000
Closed -$41.3K
ALT icon
900
CALL
Altimmune
ALT
$597M
-25,700
Closed -$423K

Similar funds

Belvedere Trading's Q1 2023 Portfolio in Review

As of Q1 2023, Belvedere Trading held 1,678 positions worth $41.3B, up 12% from $37B the previous quarter. Its ten largest holdings account for 92% of the portfolio.

Belvedere Trading's Q1 2023 filing shows 553 new, 134 increased, 156 reduced and 796 closed positions. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 279,308 shares worth $114M. The largest sale was Tesla, an estimated $80.1M.

By sector, the portfolio is most concentrated in Communication Services at 0.07% of assets, up from 0.02% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Belvedere Trading's largest Q1 2023 buy was State Street SPDR S&P 500 ETF Trust: 279,308 shares worth $114M.
  • Belvedere Trading added most to Meta Platforms (Facebook) in Q1 2023, an estimated $14.6M increase.
  • Belvedere Trading's biggest Q1 2023 reduction was Tesla, cutting an estimated $80.1M.
  • Belvedere Trading fully exited Amazon in Q1 2023, selling an estimated $30.3M.
  • Belvedere Trading's ten largest holdings make up 92% of its $41.3B portfolio in Q1 2023.
  • Belvedere Trading opened 553 new positions and closed 796 in Q1 2023.
  • Belvedere Trading's portfolio value rose 12% quarter-over-quarter to $41.3B.

Based on Belvedere Trading's 13F filing for Q1 2023, filed 15 May 2023.